| Name | tert-butyl 2-(4-chlorophenyl)piperazine-1-carboxylate |
|---|---|
| Synonyms |
1-BOC-2-(4-CHLOROPHENYL)PIPERAZINE
2-(2-HYDROXY-1,1,1,3,3,3-HEXAFLUOROPROPYL)-1-NAPHTHOL 2-(4-CHLOROPHENYL)PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER 4-(tert-Butoxycarbonyl)-3-(4-chlorophenyl)piperazine |
| Density | 1.155g/cm3 |
|---|---|
| Boiling Point | 401.2ºC at 760 mmHg |
| Molecular Formula | C15H21ClN2O2 |
| Molecular Weight | 296.79200 |
| Flash Point | 196.4ºC |
| Exact Mass | 296.12900 |
| PSA | 41.57000 |
| LogP | 3.48810 |
| Index of Refraction | 1.531 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933599090 |
|
~69%
769944-39-0 |
| Literature: MITSUBISHI PHARMA CORPORATION; SANOFI-SYNTHELABO Patent: WO2004/85408 A1, 2004 ; Location in patent: Page 264 ; WO 2004/085408 A1 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |